Terra L. Lasho

MPL515 mutations in myeloproliferative and other myeloid disorders: a study of 1182 patients

Animesh Pardanani, Ross L. Levine, Terra L. Lasho et al. · Blood · 2006 · 1K citations · Full text

Long-term survival and blast transformation in molecularly annotated essential thrombocythemia, polycythemia vera, and myelofibrosis

Ayalew Tefferi, Paola Guglielmelli, Dirk R. Larson et al. · Blood · 2014 · 712 citations · Full text

Circulating Interleukin (IL)-8, IL-2R, IL-12, and IL-15 Levels Are Independently Prognostic in Primary Myelofibrosis: A Comprehensive Cytokine Profiling Study

Ayalew Tefferi, Rakhee Vaidya, Domenica Caramazza et al. · Journal of Clinical Oncology · 2011 · 578 citations · Full text

Systemic mastocytosis in 342 consecutive adults: survival studies and prognostic factors

Ken-Hong Lim, Ayalew Tefferi, Terra L. Lasho et al. · Blood · 2009 · 567 citations

CALR vs JAK2 vs MPL-mutated or triple-negative myelofibrosis: clinical, cytogenetic and molecular comparisons

Ayalew Tefferi, Terra L. Lasho, Christy M. Finke et al. · Leukemia · 2014 · 535 citations

Hematological Malignancy, Oncology, Medicine +10